Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
29 09 2020
Historique:
received: 01 04 2020
accepted: 22 07 2020
pubmed: 31 7 2020
medline: 16 12 2020
entrez: 31 7 2020
Statut: epublish

Résumé

To ensure productive infection, herpesviruses utilize tegument proteins and nonstructural regulatory proteins to counteract cellular defense mechanisms and to reprogram cellular pathways. The M25 proteins of mouse cytomegalovirus (MCMV) belong to the betaherpesvirus UL25 gene family that encodes viral proteins implicated with regulatory functions. Through affinity purification and mass spectrometric analysis, we discovered the tumor suppressor protein p53 as a host factor interacting with the M25 proteins. M25-p53 interaction in infected and transfected cells was confirmed by coimmunoprecipitation. Moreover, the proteins colocalized in nuclear dot-like structures upon both infection and inducible expression of the two M25 isoforms. p53 accumulated in wild-type MCMV-infected cells, while this did not occur upon infection with a mutant lacking the M25 gene. Both M25 proteins were able to mediate the effect, identifying them as the first CMV proteins responsible for p53 accumulation during infection. Interaction with M25 proteins led to substantial prolongation of the half-life of p53. In contrast to the higher abundance of the p53 protein in wild-type MCMV-infected cells, the transcript levels of the prominent p53 target genes

Identifiants

pubmed: 32727874
pii: JVI.00574-20
doi: 10.1128/JVI.00574-20
pmc: PMC7527045
pii:
doi:

Substances chimiques

TP53 protein, human 0
Trp53 protein, mouse 0
Tumor Suppressor Protein p53 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Virol. 2004 Sep;78(17):9512-23
pubmed: 15308743
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210
pubmed: 30824861
Cancers (Basel). 2018 Jun 04;10(6):
pubmed: 29866997
J Virol. 2018 Apr 13;92(9):
pubmed: 29444945
Virology. 2016 Oct;497:279-293
pubmed: 27498410
Biochim Biophys Acta. 2016 Apr;1865(2):220-7
pubmed: 26951863
J Virol. 2002 Mar;76(5):2460-8
pubmed: 11836424
Front Cell Infect Microbiol. 2018 Nov 19;8:396
pubmed: 30510918
J Cell Sci. 2006 Jun 15;119(Pt 12):2457-67
pubmed: 16720642
Nature. 1992 May 7;357(6373):82-5
pubmed: 1533443
Cell. 1994 Mar 11;76(5):777-9
pubmed: 8124715
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9575-80
pubmed: 22645331
Nucleic Acids Res. 2004 Oct 14;32(18):5529-38
pubmed: 15486202
Viruses. 2017 Sep 02;9(9):
pubmed: 28869497
J Am Soc Nephrol. 2015 Jul;26(7):1513-23
pubmed: 25349197
J Virol. 2005 Oct;79(20):13037-46
pubmed: 16189006
Methods Mol Biol. 2010;634:421-30
pubmed: 20677001
J Infect Dis. 2020 Mar 5;221(Supplement_1):S60-S73
pubmed: 32134481
J Virol. 2012 Jan;86(2):806-20
pubmed: 22072767
J Virol. 1995 Nov;69(11):6697-704
pubmed: 7474079
Cell. 2014 Jun 5;157(6):1460-1472
pubmed: 24906157
PLoS Pathog. 2012 Sep;8(9):e1002908
pubmed: 22969428
Adv Virus Res. 2008;72:207-26
pubmed: 19081492
PLoS Pathog. 2011 May;7(5):e1001342
pubmed: 21589897
Cell Syst. 2016 Oct 26;3(4):361-373.e6
pubmed: 27641956
J Virol. 1997 Aug;71(8):5861-70
pubmed: 9223475
Science. 2004 Feb 6;303(5659):844-8
pubmed: 14704432
Cell. 2015 Aug 27;162(5):987-1002
pubmed: 26317467
J Biol Chem. 2007 Oct 5;282(40):29284-95
pubmed: 17698841
J Infect Dis. 2003 Mar 15;187(6):988-99
pubmed: 12660946
J Virol. 1990 May;64(5):1907-19
pubmed: 2157860
Microorganisms. 2020 May 26;8(6):
pubmed: 32466380
J Virol. 1997 Feb;71(2):1115-23
pubmed: 8995632
J Virol. 2006 Sep;80(17):8390-401
pubmed: 16912290
Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a000893
pubmed: 20463001
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Nucleic Acids Res. 2014 Jul;42(12):7666-80
pubmed: 24928858
J Virol. 2007 Feb;81(4):1934-50
pubmed: 17151099
J Virol. 1996 Sep;70(9):6097-105
pubmed: 8709233
J Virol. 1998 Mar;72(3):2033-9
pubmed: 9499057
Viruses. 2018 Dec 06;10(12):
pubmed: 30563202
Cell Death Differ. 2018 Jan;25(1):133-143
pubmed: 29125602
Exp Hematol. 2006 May;34(5):588-92
pubmed: 16647564
Mol Cell Proteomics. 2016 May;15(5):1642-57
pubmed: 26912668
Viruses. 2014 May 23;6(5):2155-85
pubmed: 24859341
Cell Cycle. 2011 May 15;10(10):1590-8
pubmed: 21490429
Elife. 2019 Dec 24;8:
pubmed: 31873071
J Virol. 2000 Jan;74(2):975-86
pubmed: 10623760
J Virol. 2007 Nov;81(21):11861-9
pubmed: 17715239
J Biol Chem. 1996 Feb 16;271(7):3534-40
pubmed: 8631958
Nat Immunol. 2018 May;19(5):453-463
pubmed: 29632329
Cancer Res. 2006 Sep 1;66(17):8356-60
pubmed: 16951143
Annu Rev Virol. 2018 Sep 29;5(1):141-164
pubmed: 29996066
Science. 1990 Aug 24;249(4971):912-5
pubmed: 2144057
J Virol. 2009 Dec;83(23):12388-98
pubmed: 19776115
PLoS Pathog. 2017 May 25;13(5):e1006382
pubmed: 28542326
J Biol Chem. 2015 Dec 25;290(52):30771-82
pubmed: 26527684
Nat Commun. 2020 Sep 24;11(1):4845
pubmed: 32973148
Cell. 1993 Nov 19;75(4):817-25
pubmed: 8242752
Sci Rep. 2017 Nov 14;7(1):15588
pubmed: 29138436
Science. 1994 Jul 15;265(5170):391-4
pubmed: 8023160
Med Microbiol Immunol. 2015 Jun;204(3):409-19
pubmed: 25776080
Arch Virol. 2000;145(4):795-803
pubmed: 10893157
J Virol. 2005 Sep;79(17):11467-75
pubmed: 16103197
J Virol. 2018 Nov 27;92(24):
pubmed: 30282718
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Virology. 1999 Sep 30;262(2):265-76
pubmed: 10502507
Microbiol Immunol. 2012 May;56(5):324-31
pubmed: 22376288
J Virol. 2001 Apr;75(8):3613-25
pubmed: 11264351
Front Biosci. 2002 Jan 01;7:d295-306
pubmed: 11779699
J Virol. 1999 May;73(5):3800-9
pubmed: 10196274
J Virol. 2010 Dec;84(23):12210-25
pubmed: 20861261
J Virol. 2013 Mar;87(5):2463-74
pubmed: 23236067
Cancer Res. 2016 Apr 15;76(8):2206-18
pubmed: 26964623
J Virol. 2004 Oct;78(20):11187-97
pubmed: 15452238
PLoS Pathog. 2016 May 06;12(5):e1005594
pubmed: 27152739
J Virol. 2009 May;83(9):4316-25
pubmed: 19224996
J Neurosci. 2013 Jan 30;33(5):2205-16
pubmed: 23365256
J Virol. 2005 Jun;79(12):7570-96
pubmed: 15919911
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2821-6
pubmed: 16477038
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
Curr Top Microbiol Immunol. 2008;325:101-15
pubmed: 18637502
Rev Med Virol. 2013 Jul;23(4):213-20
pubmed: 23255396
Nat Genet. 1992 Apr;1(1):45-9
pubmed: 1301998
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a000950
pubmed: 20457558
J Virol. 1994 Dec;68(12):8028-34
pubmed: 7966592
Curr Biol. 1994 Jan 1;4(1):1-7
pubmed: 7922305
J Virol. 2015 Dec 16;90(5):2571-85
pubmed: 26676792
Cancers (Basel). 2014 Dec 23;7(1):30-69
pubmed: 25545885
Viruses. 2010 Jan;2(1):298-313
pubmed: 21994612

Auteurs

Ivana Kutle (I)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Katarzyna M Szymańska-de Wijs (KM)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Boris Bogdanow (B)

Proteome Dynamics lab, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Department of Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany.

Berislav Cuvalo (B)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Lars Steinbrück (L)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Stipan Jonjić (S)

Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.

Karen Wagner (K)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Rainer Niedenthal (R)

Institute of Cell Biochemistry, Hannover Medical School, Hannover, Germany.

Matthias Selbach (M)

Proteome Dynamics lab, Max Delbrück Center for Molecular Medicine, Berlin, Germany.

Lüder Wiebusch (L)

Laboratory of Pediatric Molecular Biology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Martina Dezeljin (M)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Martin Messerle (M)

Institute of Virology, Hannover Medical School, Hannover, Germany messerle.martin@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH